CLINICAL ROLE -
Challenges and Opportunities with Oral Oncology Agents
Pharmacists can collaborate with oncologists to maximize patient outcomes through appropriate dispensing, side-effect monitoring, and adherence.
Read More
Specialty Pharmaceuticals: Hepatitis C Update
Researchers assess new study models and investigate triple drug therapies to fight hepatitis C infection.
Specialty Pharmaceuticals: Therapy Class Review: Blood Modifiers
The blood modifier category of drugs works stimulating bone marrow to produce more cells and they affect certain diseases such as cancer and chronic kidney failure.
Gene Therapy for Heart Disease
The next evolutionary step for specialty medications could lead to a new generation of cost-effective, noninvasive treatments for heart disease.
Specialty Pipeline for the Treatment of Type 2 Diabetes Mellitus
Newer pharmaceutical agents for the treatment of type 2 diabetes suggest a movement toward diabetes becoming a specialty disease state.
Specialty Pharmaceuticals: Self-Injectable Biologic DMARDs for the Treatment of Rheumatoid Arthritis
Specialty Pharmaceuticals: Challenges and Opportunities with Oral Oncology Agents